Partial FMRP expression is sufficient to normalize neuronal hyperactivity in Fragile X neurons

© 2019 The Authors. European Journal of Neuroscience published by Federation of European Neuroscience Societies and John Wiley & Sons Ltd. Fragile X syndrome (FXS) is the most common genetic form of intellectual disability caused by a CGG repeat expansion in the 5′-UTR of the Fragile X mental...

Full description

Bibliographic Details
Main Authors: Graef, John D, Wu, Hao, Ng, Carrie, Sun, Chicheng, Villegas, Vivian, Qadir, Deena, Jesseman, Kimberly, Warren, Stephen T, Jaenisch, Rudolf, Cacace, Angela, Wallace, Owen
Other Authors: Massachusetts Institute of Technology. Department of Biology
Format: Article
Language:English
Published: Wiley 2021
Online Access:https://hdl.handle.net/1721.1/136619
_version_ 1826203798087925760
author Graef, John D
Wu, Hao
Ng, Carrie
Sun, Chicheng
Villegas, Vivian
Qadir, Deena
Jesseman, Kimberly
Warren, Stephen T
Jaenisch, Rudolf
Cacace, Angela
Wallace, Owen
author2 Massachusetts Institute of Technology. Department of Biology
author_facet Massachusetts Institute of Technology. Department of Biology
Graef, John D
Wu, Hao
Ng, Carrie
Sun, Chicheng
Villegas, Vivian
Qadir, Deena
Jesseman, Kimberly
Warren, Stephen T
Jaenisch, Rudolf
Cacace, Angela
Wallace, Owen
author_sort Graef, John D
collection MIT
description © 2019 The Authors. European Journal of Neuroscience published by Federation of European Neuroscience Societies and John Wiley & Sons Ltd. Fragile X syndrome (FXS) is the most common genetic form of intellectual disability caused by a CGG repeat expansion in the 5′-UTR of the Fragile X mental retardation gene FMR1, triggering epigenetic silencing and the subsequent absence of the protein, FMRP. Reactivation of FMR1 represents an attractive therapeutic strategy targeting the genetic root cause of FXS. However, largely missing in the FXS field is an understanding of how much FMR1 reactivation is required to rescue FMRP-dependent mutant phenotypes. Here, we utilize FXS patient-derived excitatory neurons to model FXS in vitro and confirm that the absence of FMRP leads to neuronal hyperactivity. We further determined the levels of FMRP and the percentage of FMRP-positive cells necessary to correct this phenotype utilizing a mixed and mosaic neuronal culture system and a combination of CRISPR, antisense and expression technologies to titrate FMRP in FXS and WT neurons. Our data demonstrate that restoration of greater than 5% of overall FMRP expression levels or greater than 20% FMRP-expressing neurons in a mosaic pattern is sufficient to normalize a FMRP-dependent, hyperactive phenotype in FXS iPSC-derived neurons.
first_indexed 2024-09-23T12:43:36Z
format Article
id mit-1721.1/136619
institution Massachusetts Institute of Technology
language English
last_indexed 2024-09-23T12:43:36Z
publishDate 2021
publisher Wiley
record_format dspace
spelling mit-1721.1/1366192023-09-07T21:20:39Z Partial FMRP expression is sufficient to normalize neuronal hyperactivity in Fragile X neurons Graef, John D Wu, Hao Ng, Carrie Sun, Chicheng Villegas, Vivian Qadir, Deena Jesseman, Kimberly Warren, Stephen T Jaenisch, Rudolf Cacace, Angela Wallace, Owen Massachusetts Institute of Technology. Department of Biology Whitehead Institute for Biomedical Research © 2019 The Authors. European Journal of Neuroscience published by Federation of European Neuroscience Societies and John Wiley & Sons Ltd. Fragile X syndrome (FXS) is the most common genetic form of intellectual disability caused by a CGG repeat expansion in the 5′-UTR of the Fragile X mental retardation gene FMR1, triggering epigenetic silencing and the subsequent absence of the protein, FMRP. Reactivation of FMR1 represents an attractive therapeutic strategy targeting the genetic root cause of FXS. However, largely missing in the FXS field is an understanding of how much FMR1 reactivation is required to rescue FMRP-dependent mutant phenotypes. Here, we utilize FXS patient-derived excitatory neurons to model FXS in vitro and confirm that the absence of FMRP leads to neuronal hyperactivity. We further determined the levels of FMRP and the percentage of FMRP-positive cells necessary to correct this phenotype utilizing a mixed and mosaic neuronal culture system and a combination of CRISPR, antisense and expression technologies to titrate FMRP in FXS and WT neurons. Our data demonstrate that restoration of greater than 5% of overall FMRP expression levels or greater than 20% FMRP-expressing neurons in a mosaic pattern is sufficient to normalize a FMRP-dependent, hyperactive phenotype in FXS iPSC-derived neurons. 2021-10-27T20:36:16Z 2021-10-27T20:36:16Z 2020 2021-07-19T17:38:56Z Article http://purl.org/eprint/type/JournalArticle https://hdl.handle.net/1721.1/136619 en 10.1111/EJN.14660 European Journal of Neuroscience Creative Commons Attribution-NonCommercial-NoDerivs License http://creativecommons.org/licenses/by-nc-nd/4.0/ application/pdf Wiley Wiley
spellingShingle Graef, John D
Wu, Hao
Ng, Carrie
Sun, Chicheng
Villegas, Vivian
Qadir, Deena
Jesseman, Kimberly
Warren, Stephen T
Jaenisch, Rudolf
Cacace, Angela
Wallace, Owen
Partial FMRP expression is sufficient to normalize neuronal hyperactivity in Fragile X neurons
title Partial FMRP expression is sufficient to normalize neuronal hyperactivity in Fragile X neurons
title_full Partial FMRP expression is sufficient to normalize neuronal hyperactivity in Fragile X neurons
title_fullStr Partial FMRP expression is sufficient to normalize neuronal hyperactivity in Fragile X neurons
title_full_unstemmed Partial FMRP expression is sufficient to normalize neuronal hyperactivity in Fragile X neurons
title_short Partial FMRP expression is sufficient to normalize neuronal hyperactivity in Fragile X neurons
title_sort partial fmrp expression is sufficient to normalize neuronal hyperactivity in fragile x neurons
url https://hdl.handle.net/1721.1/136619
work_keys_str_mv AT graefjohnd partialfmrpexpressionissufficienttonormalizeneuronalhyperactivityinfragilexneurons
AT wuhao partialfmrpexpressionissufficienttonormalizeneuronalhyperactivityinfragilexneurons
AT ngcarrie partialfmrpexpressionissufficienttonormalizeneuronalhyperactivityinfragilexneurons
AT sunchicheng partialfmrpexpressionissufficienttonormalizeneuronalhyperactivityinfragilexneurons
AT villegasvivian partialfmrpexpressionissufficienttonormalizeneuronalhyperactivityinfragilexneurons
AT qadirdeena partialfmrpexpressionissufficienttonormalizeneuronalhyperactivityinfragilexneurons
AT jessemankimberly partialfmrpexpressionissufficienttonormalizeneuronalhyperactivityinfragilexneurons
AT warrenstephent partialfmrpexpressionissufficienttonormalizeneuronalhyperactivityinfragilexneurons
AT jaenischrudolf partialfmrpexpressionissufficienttonormalizeneuronalhyperactivityinfragilexneurons
AT cacaceangela partialfmrpexpressionissufficienttonormalizeneuronalhyperactivityinfragilexneurons
AT wallaceowen partialfmrpexpressionissufficienttonormalizeneuronalhyperactivityinfragilexneurons